Skip to main content
TipRanks
Go Ultimate75% OFF

H.B. Fuller Company (FUL) AI Stock Analysis

241 Followers
FUL

H.B. Fuller Company

(NYSE:FUL)

Select Model
Rating:61Neutral
Price Target:$53.00▲(10.05% Upside)
Action:reiterated
Date:10/22/26

The score is driven mainly by mixed financial fundamentals: improving margins and profitability, but notably weak cash conversion and pressured free cash flow. The latest earnings call adds support via maintained guidance and ongoing cost-savings execution, while technicals remain a headwind with the stock trading below key longer-term moving averages. Valuation is reasonable and partially offsets these risks.

Positive Factors
Margin ExpansionPricing execution and restructuring savings are currently offsetting lower volume and elevated raw-material costs. Expanding gross profit and EBITDA margins can strengthen earnings durability, improve resilience across cycles, and provide funding for ongoing operational investment.
Negative Factors
Weak Cash ConversionReported profitability is not converting efficiently into cash, limiting the funds available for debt reduction, acquisitions, and internal investment. Persistently weak conversion would leave the company more dependent on financing and less able to absorb demand or cost pressure.

H.B. Fuller Company (FUL) vs. SPDR S&P 500 ETF (SPY)

-15%-10%-5%0%5%10%15%20%FUL-13.66%SPY+11.99%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$2.59B
Dividend Yield
2.01%
Average Volume (3M)
729.01K
Price to Earnings (P/E)
13.2
Beta (1Y)
0.82
Revenue Growth
1.48%
EPS Growth
72.33%
Country
US
Employees
7,100
Sector
Basic Materials
Sector Strength
61
Industry
Chemicals - Specialty

H.B. Fuller Company Business Overview & Revenue Model

Company Description

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, He...

How the Company Makes Money

H.B. Fuller primarily makes money by selling formulated adhesive and sealant products to business customers (B2B) across multiple end markets, generating revenue from the volume of product shipped and the pricing of those products. Its core revenue s...

H.B. Fuller Company Earnings Call Summary

Earnings Call Date:Sep 23, 2026(Q3-2026)|% Change Since:-3.61%|Next Earnings Date:Jan 20, 2027
Earnings Call SentimentPositive

The call was predominantly positive, with strong third-quarter revenue, EBITDA, margin, EPS, cash flow, segment performance, Quantum Leap execution, and progress toward closing the AMS acquisition. The main challenges were lower volumes, volatile demand, elevated raw material costs, supply chain disruption, weakness in electronics, construction, China, and portions of HHC and BAS. Management remained confident in continued growth, margin expansion, savings realization, cash flow improvement, and deleveraging.

Positive Updates

Strong Third-Quarter Financial Performance
Revenue increased 5.2% year-over-year, while organic revenue increased 4.4%, driven by 7.4% pricing that partially offset lower volume. Adjusted EBITDA rose 9% to $187 million, adjusted EBITDA margin expanded 80 basis points to 19.9%, and adjusted EPS increased 21% to $1.52.

Negative Updates

Lower Volume Offset Organic Growth
Third-quarter organic growth of 4.4% was driven by 7.4% pricing that was partially offset by lower volume year-over-year. Fiscal 2026 guidance continues to call for volume to decline low single digits.

Company Guidance

For fiscal 2026, excluding the impact of the proposed acquisition of Advanced Medical Solutions, net revenue is still expected to be up mid-single digits, organic revenue is still expected to be up low single digits versus fiscal 2025, pricing up mid-single digits and volume down low single digits; adjusted EBITDA is now expected to be in the range of $655 million to $670 million, adjusted EPS in the range of $4.70 to $4.85, and cash flow from operations, excluding AMS-related items, in the range of $300 million to $325 million. Quantum Leap is expected to deliver approximately $75 million of annualized conversion cost savings by the end of 2030, with approximately $25 million realized through the end of 2026 and an additional $20 million to $25 million of incremental savings in 2027; capital investment is expected to be $150 million over the life of the program, roughly $50 million in 2026 and less than $25 million in 2027, with approximately $50 million of total onetime cash costs, about 1/3 already realized. The footprint is expected to decline from 82 manufacturing facilities at the end of 2024 to approximately 62 by the end of 2026, below 60 by the end of 2027 excluding AMS, and toward 55, while AMS is expected to be growing about 8% a year on average and leverage is expected to return to the targeted range of 2.5 to 3x within 2 years of closing.

H.B. Fuller Company Financial Statement Overview

Summary

Profitability is improving (better gross and net margins, solid EBIT margin), but overall quality is held back by weak cash conversion and sharply lower free cash flow. Leverage is trending better but remains meaningful versus mid-level returns, limiting flexibility if end-markets soften.

Income Statement

72Positive

Balance Sheet

60Neutral

Cash Flow

44Neutral
Financial statement breakdown
BreakdownTTMNov 2025Nov 2024Nov 2023Nov 2022Nov 2021
Income Statement
Total Revenue3.55B3.47B3.57B3.51B3.75B3.28B
Gross Profit1.17B1.10B1.07B1.02B963.55M845.13M
EBITDA540.79M527.08M490.50M528.60M490.43M438.12M
Net Income197.76M151.97M130.26M144.91M180.31M161.39M
Balance Sheet
Total Assets5.43B5.18B4.93B4.72B4.46B4.27B
Cash, Cash Equivalents and Short-Term Investments97.23M107.21M169.35M179.45M79.91M61.79M
Total Debt2.05B2.02B2.07B1.90B1.80B1.65B
Total Liabilities3.26B3.18B3.10B2.97B2.85B2.68B
Stockholders Equity2.17B2.00B1.83B1.76B1.61B1.60B
Cash Flow
Free Cash Flow100.03M121.22M163.20M259.26M126.55M117.23M
Operating Cash Flow289.37M263.49M302.44M378.40M256.51M213.32M
Investing Cash Flow-202.04M-232.25M-407.08M-319.20M-375.29M-94.66M
Financing Cash Flow-125.61M-107.90M112.09M35.14M160.32M-154.07M

H.B. Fuller Company Technical Analysis

Technical Analysis SentimentNegative
Last Price48.16

Price Trends

50DMA50.09Negative
100DMA53.50Negative
200DMA57.08Negative

Market Momentum

MACD-0.52Positive
RSI40.43Neutral
STOCH11.07Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FUL, the sentiment is Negative. The current price of 48.16 is below the 20-day moving average (MA) of 49.94, below the 50-day MA of 50.09, and below the 200-day MA of 57.08, indicating a bearish trend. The MACD of -0.52 indicates Positive momentum. The RSI at 40.43 is Neutral, neither overbought nor oversold. The STOCH value of 11.07 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for FUL.

H.B. Fuller Company Risk Analysis

H.B. Fuller Company disclosed 21 risk factors in its most recent earnings report. H.B. Fuller Company reported the most risks in the "Legal & Regulatory" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Legal & Regulatory - Litigation, compliance, new legislation, and taxation risks

Latest Risks Added

2 New Risks
1.Failure to comply with regulatory reporting requirements may negatively impact our financial results and reputation.Q4, 2025
2.Our business exposes us to potential product liability, warranty, and tort claims, and recalls, which may negatively impact our operations, financial results, and reputation.Q4, 2023

H.B. Fuller Company Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

FUL against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
RPMRPM72Outperform$13.33B19.2521.13%2.09%5.96%0.68%
AXTAAXTA68Neutral$7.68B23.3713.48%―0.14%-25.40%
EMNEMN65Neutral$7.13B11.0010.63%5.39%0.40%-6.58%
PPGPPG62Neutral$27.12B17.4419.05%2.36%6.39%27.29%
Sector *61Neutral$10.43B7.12-0.05%2.87%2.86%-36.73%
FULFUL61Neutral$2.59B13.239.51%2.01%1.48%72.33%
ASHASH61Neutral$3.40B848.890.21%2.19%2.08%―

* Basic Materials Sector Average

Performance Comparison

0%20%40%FULASHEMNPPGRPMAXTADec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
FUL and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
FULH.B. Fuller Company48.16-8.22-14.58%
ASHAshland Global Holdings, Inc.76.4027.4055.92%
EMNEastman Chemical Company62.365.679.99%
PPGPpg Industries, Inc.122.7826.4527.46%
RPMRPM International104.541.581.54%
AXTAAxalta Coating Systems36.466.3020.89%

H.B. Fuller Company Corporate Events

Business Operations and StrategyM&A TransactionsPrivate Placements and Financing

H.B. Fuller Raises $850 Million in Senior Notes

Positive
Oct 22, 2026

On October 21, 2026, H.B. Fuller completed a private offering of $850 million in 7.625% senior unsecured notes due October 15, 2034, sold to qualified institutional buyers under Rule 144A and to certain investors outside the U.S. under Regulation S....

Business Operations and StrategyM&A TransactionsPrivate Placements and Financing

H.B. Fuller Prices New Senior Notes for Acquisition

Positive
Oct 9, 2026

On Oct. 8, 2026, H.B. Fuller Company announced it had priced an $850 million offering of new 7.625% senior unsecured notes due 2034 at par in a private placement limited to qualified institutional buyers and certain non-U.S. investors. The notes, exp...

Business Operations and StrategyFinancial DisclosuresM&A TransactionsPrivate Placements and Financing

H.B. Fuller Raises $950M Notes to Fund AMS Deal

Neutral
Oct 6, 2026

H.B. Fuller Company has launched a private offering of $950 million in new senior unsecured notes due 2034, sold to institutional and non-U.S. investors under exemptions from U.S. securities registration rules. The company plans to use the proceeds,...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 22, 2026